Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testosterone Reference Ranges in Women, Adolescent Girls, and Children: The 2024 PCOS Challenge-CDC Stakeholder Meeting.

The Journal of clinical endocrinology and metabolism·2026
Same author

Correlation and Commutability Study between an LC-MS-Based Reference Measurement Procedure and Immunoassays Measuring Apolipoprotein A-I and Apolipoprotein B.

Clinical chemistry·2026
Same author

Prediction of Mesenchymal Stromal Cell Immune Suppression Using Live Imaging in a Three-Dimensional Microfluidic Device.

ACS biomaterials science & engineering·2026
Same author

A microgel bone marrow model of mesenchymal stromal cell paracrine signaling supporting hematopoietic stem cell retention.

Acta biomaterialia·2026
Same author

Poldip2 deficiency attenuates lung disease severity in a mouse model of COVID-19.

PloS one·2026
Same author

Highly specific ID-UHPLC-MS/MS method for analyzing polar and non-polar steroid hormones.

Analytical and bioanalytical chemistry·2026

Related Experiment Video

Updated: May 7, 2026

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering
10:18

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering

Published on: September 19, 2011

26.9K

Cellular encapsulation enhances cardiac repair.

Rebecca D Levit1, Natalia Landázuri, Edward A Phelps

  • 1Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, 30322, GA.

Journal of the American Heart Association
|October 12, 2013
PubMed
Summary

Encapsulating human mesenchymal stem cells (hMSCs) in alginate hydrogels significantly improved cardiac function and cell retention after myocardial infarction in rats. This strategy enhances cell survival and promotes cardiac repair by increasing microvasculature and reducing scar tissue.

Keywords:
angiogenesiscardiovascular diseasesheart failureischemiamyocardial infarction

More Related Videos

Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications
08:41

Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications

Published on: December 4, 2017

8.4K
Cellular Encapsulation in 3D Hydrogels for Tissue Engineering
09:37

Cellular Encapsulation in 3D Hydrogels for Tissue Engineering

Published on: October 26, 2009

38.3K

Related Experiment Videos

Last Updated: May 7, 2026

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering
10:18

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering

Published on: September 19, 2011

26.9K
Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications
08:41

Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications

Published on: December 4, 2017

8.4K
Cellular Encapsulation in 3D Hydrogels for Tissue Engineering
09:37

Cellular Encapsulation in 3D Hydrogels for Tissue Engineering

Published on: October 26, 2009

38.3K

Area of Science:

  • Regenerative Medicine
  • Biomaterials Science
  • Cardiovascular Research

Background:

  • Stem cell therapy shows promise for cardiac repair but faces challenges with cell retention, viability, and efficacy.
  • Cell encapsulation in biomaterials like alginate is a potential strategy to improve cell survival and therapeutic effects.

Purpose of the Study:

  • To evaluate the efficacy of alginate-encapsulated human mesenchymal stem cells (hMSCs) for cardiac repair in a rat myocardial infarction (MI) model.
  • To assess the impact of encapsulation on hMSC retention, cardiac function, scar size, and microvascularization post-MI.

Main Methods:

  • Human mesenchymal stem cells (hMSCs) were encapsulated in alginate and delivered via a hydrogel patch to the infarcted heart in rats.
  • Cell retention was monitored using bioluminescence imaging (BLI).
  • Cardiac function was assessed using transthoracic echocardiography (TTE) and cardiac magnetic resonance imaging (CMR). Microvasculature and scar size were quantified histologically.

Main Results:

  • Encapsulated hMSC treatment significantly improved ejection fraction (56 ± 1%) and fractional shortening compared to control groups.
  • Alginate encapsulation led to superior hMSC retention in the heart.
  • Significant reductions in scar size (7 ± 1%) and marked increases in peri-infarct microvascular density (828 ± 56 vessels/mm²) were observed in the encapsulated hMSC group.

Conclusions:

  • Alginate encapsulation enhances the retention and therapeutic efficacy of hMSCs for cardiac repair post-MI.
  • The strategy promotes paracrine effects, including increased microvasculature and reduced scar size, leading to improved cardiac function.
  • Encapsulated MSCs represent a promising, translatable approach for optimizing regenerative therapies in cardiovascular disease.